📊 Score Breakdown
Offering Ability
60
Cash Runway
65
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
31%
📉 Score Deterioration
40%
• Score rose 37 points recently (worsening)
💰 Capital Raise
33%
• Under 12 months cash (9mo)
• Active ATM program with $20M remaining capacity
🔄 Reverse Split
10%
• 9 months cash with weak price
💹 Market Data
Market Cap$160.13M
Shares Outstanding36.23M
Float30.45M
Cash$6.71M
Debt$934.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 31.9% shares (2025Q4 vs prior)
30 institutional holders · 5.33M shares
#1
Anson Funds Management LP
3.04M shares
#2
VANGUARD GROUP INC
729.8K shares
#3
COMMONWEALTH EQUITY SERVICES, LLC
366.6K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest4.67M
Days to Cover4.2
% of Float15.3%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
8-K
8K EVENT
Mar 24, 2026
4
INSIDER TRANSACTION
Feb 17, 2026
3
FORM3
Feb 17, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for NRXP
📊 NRXP FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 NRXP Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.